1. Home
  2. GKOS vs LFUS Comparison

GKOS vs LFUS Comparison

Compare GKOS & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LFUS
  • Stock Information
  • Founded
  • GKOS 1998
  • LFUS 1927
  • Country
  • GKOS United States
  • LFUS United States
  • Employees
  • GKOS N/A
  • LFUS N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • LFUS Electrical Products
  • Sector
  • GKOS Health Care
  • LFUS Energy
  • Exchange
  • GKOS Nasdaq
  • LFUS Nasdaq
  • Market Cap
  • GKOS 7.4B
  • LFUS 6.3B
  • IPO Year
  • GKOS 2015
  • LFUS N/A
  • Fundamental
  • Price
  • GKOS $138.39
  • LFUS $241.09
  • Analyst Decision
  • GKOS Strong Buy
  • LFUS Buy
  • Analyst Count
  • GKOS 12
  • LFUS 5
  • Target Price
  • GKOS $135.08
  • LFUS $278.75
  • AVG Volume (30 Days)
  • GKOS 600.5K
  • LFUS 107.5K
  • Earning Date
  • GKOS 11-04-2024
  • LFUS 10-29-2024
  • Dividend Yield
  • GKOS N/A
  • LFUS 1.16%
  • EPS Growth
  • GKOS N/A
  • LFUS N/A
  • EPS
  • GKOS N/A
  • LFUS 7.78
  • Revenue
  • GKOS $360,347,000.00
  • LFUS $2,195,070,000.00
  • Revenue This Year
  • GKOS $22.68
  • LFUS N/A
  • Revenue Next Year
  • GKOS $24.98
  • LFUS $4.76
  • P/E Ratio
  • GKOS N/A
  • LFUS $30.99
  • Revenue Growth
  • GKOS 18.70
  • LFUS N/A
  • 52 Week Low
  • GKOS $59.22
  • LFUS $222.91
  • 52 Week High
  • GKOS $145.84
  • LFUS $275.58
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 55.15
  • LFUS 36.55
  • Support Level
  • GKOS $124.60
  • LFUS $256.28
  • Resistance Level
  • GKOS $145.84
  • LFUS $263.04
  • Average True Range (ATR)
  • GKOS 5.15
  • LFUS 5.74
  • MACD
  • GKOS 0.30
  • LFUS -0.81
  • Stochastic Oscillator
  • GKOS 64.92
  • LFUS 0.81

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About LFUS Littelfuse Inc.

Littelfuse is a primary provider of circuit protection products (such as fuses and relays) into the transportation, industrial, telecommunications, and consumer electronics end markets. The firm is also increasing its power semiconductor business, where it predominantly serves industrial end markets and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.

Share on Social Networks: